ATCC Screening Fee
ACS-2103F ™
Screening fee is applied to specific ATCC cell lines designated for "Screening Use". "Screening Use" is defined as use of the applicable cell line in small molecule and biologic drug discovery, including initial target identification and validation, assay development, high throughput screening, hit identification, lead optimization, and selection of candidates for clinical development.
As of March FY2026, ATCC has transitioned the screening fee to a one-time fee payable for each product intended for screening use.
If you have added the screening fee to our products in the past – no further action is needed. We do not require any renewal fees going forward. For new screening uses we no longer require the Material Transfer Agreement Addendum for Screening Applications.
How to add the screening fee to our products
- Add the applicable screening fee to your cart when purchasing the associated ATCC product. One screening fee per cell line used for screening.
- For assistance, you can reach out to [email protected]
- For international customers – please reach out to your local distribution partner in your region. Click this link to Determine Your Distributor.